Ponatinib (PON) in patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) and the T315I mutation (mut): 4-year results from OPTIC

被引：0

作者：

Deininger, Michael

Apperley, Jane

Arthur, Christopher Kevin

Chuah, Charles

Hochhaus, Andreas

de Lavallade, Hugues

Lipton, Jeffrey Howard

Lomaia, Elza

McCloskey, James K.

Maness, Lori J.

Mauro, Michael J.

Moiraghi, Beatriz

Pavlovsky, Carolina

Rosti, Gianantonio

Rousselot, Philippe

Sutton, Maria Undurraga

Ren, Xiaowei

Vorog, Alexander

Kantarjian, Hagop M.

Cortes, Jorge E.

机构：

[1] Versiti Blood Res Inst, Milwaukee, WI USA

[2] Imperial Coll London, London, England

[3] Royal North Shore Hosp, St Leonards, NSW, Australia

[4] Duke NUS Med Sch, Singapore Gen Hosp, Singapore, Singapore

[5] Univ Klinikum Jena, Jena, Germany

[6] Kings Coll Hosp NHS Fdn, London, England

[7] Princess Margaret Canc Ctr, Toronto, ON, Canada

[8] Almazov Natl Med Res Ctr, St Petersburg, Russia

[9] Hackensack Meridian Hlth, John Theurer Canc Ctr, Hackensack, NJ USA

[10] Univ Nebraska Med Ctr, Omaha, NE USA

[11] Mem Sloan Kettering, New York, NY USA

[12] Hosp Jose Maria Ramos Mejia, Buenos Aires, DF, Argentina

[13] Fundaleu, Buenos Aires, DF, Argentina

[14] IRCCS Ist Romagnolo Tumori IRST Dino Amadori, Meldola, FC, Italy

[15] Ctr Hosp Versailles Univ Versailles St Quentin En, Paris, France

[16] Hosp Salvador, Santiago, Chile

[17] Takeda Dev Ctr Amer Inc, Lexington, MA USA

[18] City Hope Natl Med Ctr, Duarte, CA USA

[19] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6501

引用

页数：1